Rituximab Combined With Chemotherapy in Burkitt's Lymphoma

Clinical trial NCT00388193 · COMPLETED

Trial details

NCT number: NCT00388193
Sponsor: PETHEMA Foundation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Burkitt's Lymphoma

Start date: 2006-08-01
Primary completion: 2013-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.